{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T22:26:03Z","timestamp":1762295163855},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[1985,7,1]],"date-time":"1985-07-01T00:00:00Z","timestamp":489024000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arch Otorhinolaryngol"],"published-print":{"date-parts":[[1985,7]]},"DOI":"10.1007\/bf00464409","type":"journal-article","created":{"date-parts":[[2004,11,14]],"date-time":"2004-11-14T13:10:38Z","timestamp":1100437838000},"page":"67-70","source":"Crossref","is-referenced-by-count":21,"title":["The effect of flavone treatment on human otosclerotic ossicle organ cultures"],"prefix":"10.1007","volume":"242","author":[{"given":"I.","family":"Sziklai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.","family":"Rib\ufffdri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1007\/BF01915343","volume":"34","author":"A Beretz","year":"1978","unstructured":"Beretz A, Anton R, Stoclet JC (1978) Flavonoid compounds are potent inhibitors of cyclic AMP phosphodiesterase. Experientia 34:1054?1055","journal-title":"Experientia"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"3597","DOI":"10.1016\/0006-2952(82)90581-0","volume":"31","author":"A Beretz","year":"1981","unstructured":"Beretz A, Stierle A, Anton R, Cazenave JP (1981) Role of cyclic AMP in the inhibition of human platelet aggregation by Quercetin, a flavonoid that potentiates the effect of prostacyclin. Biochem Pharmacol 31:3597?3600","journal-title":"Biochem Pharmacol"},{"key":"CR3","first-page":"356","volume":"3","author":"JR Causse","year":"1982","unstructured":"Causse JR, Uriel J, Berges J, Shambough GE Jr, Bretlau P, Causse JB (1982) The enzymatic mechanism of the otospongiotic disease and NaF action on the enzymatic balance. Am J Otol 3:356?374","journal-title":"Am J Otol"},{"key":"CR4","first-page":"1","volume":"272","author":"LG Chevance","year":"1970","unstructured":"Chevance LG, Bretlau P, J\u00f6rgensen MB, Causse J (1970) Otosclerosis. An electron microscopic and cytochemical study. Acta Otolaryngol (Stockh) [Suppl] 272:1?44","journal-title":"Acta Otolaryngol (Stockh) [Suppl]"},{"key":"CR5","first-page":"556","volume":"16","author":"JG Ferrell Jr","year":"1979","unstructured":"Ferrell JG Jr, Chang Sing PDG, Loew G, King R, Mansour JM, Mansour TE (1979) Structure activity studies of flavonoids as inhibitors of cAMP phosphodiesterase and relationship to quantum chemical indices. Mol Pharmacol 16:556?568","journal-title":"Mol Pharmacol"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3109\/00313028409067908","volume":"16","author":"PV Iyer","year":"1984","unstructured":"Iyer PV, Cristwood RE (1984) Histopathology of the stapes in otosclerosis. Pathology 16:30?38","journal-title":"Pathology"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1001\/archotol.1969.00770020343022","volume":"89","author":"GT Nager","year":"1969","unstructured":"Nager GT (1969) Histopathology of otosclerosis. Arch Otolaryngol 89:341?363","journal-title":"Arch Otolaryngol"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1288\/00005537-198404000-00015","volume":"94","author":"C Parahy","year":"1984","unstructured":"Parahy C, Linthicum FH Jr (1984) Otosclerosis and otospongiosis: clinical and histological comparisons. Laryngoscope 94:508?512","journal-title":"Laryngoscope"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1021\/bi00782a009","volume":"10","author":"B Peterkofsky","year":"1971","unstructured":"Peterkofsky B, Diegelman R (1971) Use of a mixture of proteinase-free collagenase for the specific assay of radioactive collagen in the presence of other proteins. Biochemistry 10:988?993","journal-title":"Biochemistry"},{"key":"CR10","first-page":"95","volume":"28","author":"O Rib\u00e1ri","year":"1982","unstructured":"Rib\u00e1ri O (1982) Medicamentous treatment of the otosclerotic process. F\u00fcl-orr-g\u00e9gegy\u00f3gy\u00e1szat [Suppl] 28:95?100","journal-title":"F\u00fcl-orr-g\u00e9gegy\u00f3gy\u00e1szat [Suppl]"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"580","DOI":"10.3109\/00016488309139446","volume":"95","author":"O Rib\u00e1ri","year":"1983","unstructured":"Rib\u00e1ri O, Sziklai I (1983) Examination of noncollagen protein composition of the footplate and superstructure of the otosclerotic stapes. Acta Otolaryngol (Stockh) 95:580?584","journal-title":"Acta Otolaryngol (Stockh)"},{"key":"CR12","first-page":"28","volume-title":"Aktuelles in der Otorhinolaryngologie","author":"O Rib\u00e1ri","year":"1984","unstructured":"Rib\u00e1ri O, Sziklai I (1984) Biochemische Ver\u00e4nderungen in otosklerotischen Geh\u00f6rknochen und der Perilymphe. In: Majer EH, Zrunek M (eds) Aktuelles in der Otorhinolaryngologie. Thieme, Stuttgart New York, pp 28?31"},{"key":"CR13","first-page":"547","volume-title":"Proceedings of the XIIth World Congress, Budapest","author":"O Rib\u00e1ri","year":"1981","unstructured":"Rib\u00e1ri O, Kiss JG, Tomity I, J\u00f3ri J, Stanzel Gy (1981) The effect of Ipriflavon (Yambolap) on the otosclerotic process. In: Surj\u00e1n L, Bod\u00f3 Gy (eds) Proceedings of the XIIth World Congress, Budapest. Akad\u00e9miai Publishing House, Hungary, pp 547?549"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/BF00454303","volume":"238","author":"O Rib\u00e1ri","year":"1983","unstructured":"Rib\u00e1ri O, Sziklai I, Kiss JG, Soh\u00e1r I (1983) Cathepsin B activity in otosclerosis. Arch Otorhinolaryngol 238:123?125","journal-title":"Arch Otorhinolaryngol"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1001\/archotol.1969.00770020383026","volume":"89","author":"GE Shambough Jr","year":"1969","unstructured":"Shambough GE Jr (1969) Sodium fluoride for inactivation of the otosclerotic lesion: present status. Arch Otolaryngol 89:381?382","journal-title":"Arch Otolaryngol"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0003-9861(83)90187-X","volume":"224","author":"GL Wong","year":"1983","unstructured":"Wong GL, Kocour BA (1983) Differential sensitivity of osteoclasts and osteoblasts suggests that prostaglandin E1 effects on bone may be mediated primarily through the osteoclasts. Arch Biochem Biophys 224:29?35","journal-title":"Arch Biochem Biophys"}],"container-title":["Archives of Oto-Rhino-Laryngology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00464409.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00464409\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00464409","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,4]],"date-time":"2019-04-04T02:48:38Z","timestamp":1554346118000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00464409"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1985,7]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1985,7]]}},"alternative-id":["BF00464409"],"URL":"https:\/\/doi.org\/10.1007\/bf00464409","relation":{},"ISSN":["0302-9530","1434-4726"],"issn-type":[{"value":"0302-9530","type":"print"},{"value":"1434-4726","type":"electronic"}],"subject":[],"published":{"date-parts":[[1985,7]]}}}